Pokhrel, AnilSharma, AnubhavKhatiwada, DikshyaLamsal, JagdishAdhikary, Laxman2025-09-282025-09-282023https://hdl.handle.net/20.500.14572/2415Anil Pokhrel Department of Nephrology, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu Nepal Anubhav Sharma Department of Internal Medicine, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal Dikshya Khatiwada Star Hospital, Sanepa, Lalitpur, Nepal Jagdish Lamsal Department of Nephrology, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal Laxman Adhikary Department of Nephrology, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, NepalAbstract Introduction: Administration of an intravenous contrast medium, which is used in various routine hospital procedures, can lead to the development of nephropathy in some patients. This contrast-induced nephropathy is one of the most common reasons for hospital-acquired acute kidney injury. This study aimed to find out the prevalence of contrast-induced nephropathy among patients administered with contrast material at a tertiary care centre. Methods: This descriptive cross-sectional study was conducted from 4 March 2022 to 23 May 2022 at a tertiary care centre after taking ethical approval from the Institutional Review Committee (Reference number: 0812202106). Patients administered with an intravenous contrast medium for diagnostic imaging were included in the study. Data including sociodemographic variables and renal function test results were collected. A convenience sampling method was used. Point estimate was done and 95% Confidence Interval was calculated. Results: Among 174 participants, contrast-induced nephropathy was found in 86 (48.31%) (48.24-48.39, 95% Confidence Interval). Conclusions: The study showed that the prevalence of contrast-induced nephropathy was higher than findings from other studies done in a similar setting.en-USContrast materialKidney diseasePrevalenceArticle